Adial Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Liabilities, Current
Adial Pharmaceuticals, Inc. (ADIL) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $365.74 thousand as of 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2024-04-01
- 2022-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $365.74K.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2022-12-31 | $365.74K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |